| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +53 K | 100% | $1.20 | +$63.6 K |
| Sells | 0 | ||||
| Net | +1 | +53 K | 100% | +$63.6 K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Mark Erlander | Chief Executive Officer, Director | $5.64 M | Mar 7, 2024 | ||
| E. James Levine | Chief Financial Officer | $2.5 M | Mar 7, 2024 | ||
| Vicki Kelemen | Exec. VP and COO | $1.82 M | Mar 15, 2023 | ||
| Tod Smeal | Chief Scientific Officer | $1.68 M | Mar 7, 2024 | ||
| Fairooz Kabbinavar | Chief Medical Officer | $1.64 M | Mar 7, 2024 | ||
| Gary Pace | Director | $1.34 M | +$63.6 K | +4.99% | Jun 27, 2024 |
| Thomas Adams | Former Director | $1.24 M | Jun 10, 2021 | ||
| Katherine Ruffner | Chief Medical Officer | $962 K | Mar 9, 2022 | ||
| Rodney Markin | Director | $473 K | Jun 27, 2024 | ||
| James Armitage | Director | $382 K | Jun 27, 2024 | ||
| Lale White | Director | $382 K | Jun 27, 2024 | ||
| Mani Mohindru | Director | $333 K | Jun 27, 2024 | ||
| Renee P. Tannenbaum | Director | $333 K | Jun 27, 2024 | ||
| John Brancaccio | Former Director | $326 K | Jun 9, 2022 | ||
| Gary Jacob | Former Director | $198 K | Jun 10, 2021 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|